Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Some dibenzo compounds might help treat cancer with fewer side effects.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Developing microRNA-based treatments is hard but has potential.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some drugs for inflammation may cause psoriasis-like hair loss.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

The combination of encorafenib and binimetinib caused few skin issues.

The treatment is safe and shows promise for metastatic breast cancer.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Stopping oral contraceptives improved symptoms of porphyria cutanea tarda in a young woman.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Coal tar shampoo increases enzyme activity in hair follicles, enhancing carcinogen binding to DNA.